Document is current
Any future updates will be listed below
-
Authors
Matharu, Navneet
Zhao, Jingjing https://orcid.org/0000-0002-4298-8817
Sohota, Ajuni
Deng, Linbei
Hung, Yan
Li, Zizheng https://orcid.org/0000-0002-6953-7733
An, Kelly
Sims, Jasmine
Rattanasopha, Sawitree
Meyer, Thomas J. https://orcid.org/0000-0002-7185-5597
Carbone, Lucia https://orcid.org/0000-0002-2118-107X
Kircher, Martin https://orcid.org/0000-0001-9278-5471
Ahituv, Nadav https://orcid.org/0000-0002-7434-8144
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (UM1HG009408, UM1HG011966, UM1HG011966)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM142112)
- License Information
-
More Information
Article History
Received: 11 April 2024
Accepted: 18 April 2025
First Online: 9 May 2025
Competing interests
: N.M. is a Cofounder and the Chief Scientific Officer for Regel Therapeutics Inc. N.A. is a Cofounder and on the scientific advisory board of Regel Therapeutics Inc. N.A. received funding from BioMarin Pharmaceutical Inc. The remaining authors declare no competing interests.
